Research ArticleAnnual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), Miami, Florida, USA, July 14–16, 2016
Defining Outcome Measures for Psoriasis: The IDEOM Report from the GRAPPA 2016 Annual Meeting
Kristina Callis Duffin, Alice B. Gottlieb, Joseph F. Merola, John Latella, Amit Garg and April W. Armstrong
The Journal of Rheumatology May 2017, 44 (5) 701-702; DOI: https://doi.org/10.3899/jrheum.170151
Kristina Callis Duffin
From the University of Utah, Salt Lake City, Utah; New York Medical College, Valhalla; Hofstra Northwell School of Medicine, Hempstead, New York; Department of Dermatology and Medicine, Division of Rheumatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts; International Dermatology Outcome Measurers, West Granby, Connecticut; University of Southern California, Los Angeles, California,
USA.
Alice B. Gottlieb
Joseph F. Merola
John Latella
Amit Garg
REFERENCES
- 1.↵
- Gottlieb AB,
- Armstrong AW,
- Christensen R,
- Garg A,
- Duffin KC,
- Boehncke WH,
- et al.
- 2.↵
- 3.↵
- Merola JF,
- Armstrong AW,
- Saraiya A,
- Latella J,
- Garg A,
- Callis Duffin K,
- et al.
- 4.↵
- Greb JE,
- Merola J,
- Garg A,
- Latella J,
- Howard L,
- Acharya N,
- et al.
In this issue
The Journal of Rheumatology
Vol. 44, Issue 5
1 May 2017
Defining Outcome Measures for Psoriasis: The IDEOM Report from the GRAPPA 2016 Annual Meeting
Kristina Callis Duffin, Alice B. Gottlieb, Joseph F. Merola, John Latella, Amit Garg, April W. Armstrong
The Journal of Rheumatology May 2017, 44 (5) 701-702; DOI: 10.3899/jrheum.170151